BGNCX | RGVAX | BGNCX / RGVAX | |
Total Expense Ratio | 1.55 | 1.33 | 117% |
Annual Report Gross Expense Ratio | 1.55 | 1.37 | 113% |
Fund Existence | 15 years | 23 years | - |
Gain YTD | 2.120 | 2.996 | 71% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 362M | 22.7B | 2% |
Annual Yield % from dividends | 2.83 | 3.43 | 83% |
Returns for 1 year | 2.73 | 4.18 | 65% |
Returns for 3 years | 2.62 | 2.09 | 125% |
Returns for 5 years | -10.37 | -11.50 | 90% |
Returns for 10 years | -2.98 | -2.35 | 127% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RTOUX | 39.08 | -0.01 | -0.03% |
Russell Inv Tax-Managed US Mid&Sm Cap M | |||
SHSCX | 48.14 | -0.17 | -0.35% |
BlackRock Health Sciences Opps Inv C | |||
IGNCX | 13.00 | -0.09 | -0.69% |
Macquarie Natural Resources C | |||
ANTGX | 9.85 | -0.08 | -0.81% |
American Century Non-US Intrs Val G | |||
EILIX | 13.65 | -0.14 | -1.02% |
Eaton Vance International Small-Cap I |